NJCBA Statement on Passage of Medical Marijuana & Cannabidol Research Expansion Act

By Published On: November 21, 2022Categories: Press Releases

Trenton — New Jersey CannaBusiness Association (NJCBA) President Edmund DeVeaux issued the following statement today regarding passage of the federal Medical Marijuana and Cannabidiol Research Expansion Act, which expands research into cannabis-derived medications:

“Each day brings more positive developments in the cannabis cause. Expanding and actually encouraging research into cannabis-derived medications is a commonsense measure that will better the lives of countless individuals. Moreover, it is a great step forward in the continued normalization of the growth and usage of cannabis.

“Hopefully this is a sign of more positive developments to come, including passage of the SAFE Banking Act and removing cannabis as a Schedule 1 substance. In the meantime, we look forward to President Biden signing this legislation.”

Share This Story, Choose Your Platform!

Recent Posts
Go to Top